Amlodipine Besylate Tablet
Product Images NDC 51655-044

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Amlodipine Besylate (NDC 51655-044). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Northwind Health Company, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label (51655 044 52 Rev A 11 23)

Label for Amlodipine Besylate Tablets USP 5 mg, oral tablet dosage form. The package contains 30 tablets labeled for prescription use only. It includes storage instructions, manufacturer information (Northwind Pharmaceuticals), and a QR code. The label specifies to store at controlled room temperature and to protect from light and moisture.*

FDA Label Image

Image (Dc48db65 Ee80 4852 A3aa A23ec74f4416 01)

Chemical structure diagram of amlodipine besylate, showing its molecular framework including rings, functional groups, and various atoms such as chlorine and oxygen.*

FDA Label Image

Image2 (Dc48db65 Ee80 4852 A3aa A23ec74f4416 02)

A Kaplan-Meier event rate curve over 24 months comparing Amlodipine and Placebo groups. The y-axis represents event rate, and the x-axis represents time in months, with the number of subjects at risk noted. The graph includes statistical data with a p-value of 0.003, hazard ratio of 0.691, and 95% confidence interval from 0.54 to 0.88.*

FDA Label Image

Image3 (Dc48db65 Ee80 4852 A3aa A23ec74f4416 03)

A forest plot depicting hazard ratios with 95% confidence intervals comparing Amlodipine to placebo across various patient subgroups, including overall patients, age groups (<65, ≥65), gender, baseline sitting systolic blood pressure, baseline vessel disease, baseline vessels with stenosis, and PCI-stent strata. The horizontal axis represents the hazard ratio from 0.0 to 2.0, with a vertical line at 1.0 indicating no effect. Data points favoring Amlodipine are left of the line; those favoring placebo are right.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.